Comparing two diabetes medications for weight management
Treatments studied
Part of Hormones & metabolism clinical trials.
This study compares two diabetes medications, dapagliflozin and empagliflozin, to see which is more effective, safe, and affordable for people with type 2 diabetes and a high body weight. Both medications help lower blood sugar and may also help with weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have type 2 diabetes.
- Your most recent A1C (blood sugar test) is between 7% and 10%.
- You are currently taking metformin (with or without other diabetes pills).
- Your body mass index (BMI) is 23 or higher.
- You have not used SGLT2 inhibitors, insulin, or GLP-1 receptor agonists in the last 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a type of diabetes medicine called SGLT2 inhibitors affects how the liver makes sugar. It may help researchers better understand how to manage blood sugar in people with type 2 diabetes.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
This trial tests how stopping a type 2 diabetes medication called an SGLT2 inhibitor affects the liver's production of sugar and ketones. It may help understand better ways to manage diabetes.
This study tests a new diabetes medicine called Enavogliflozin against an older drug, Pioglitazone, to see which works better for lowering blood sugar and improving heart health. If you have type 2 diabetes, take metformin plus another pill, and your A1C is between 7 and 10.5, this study may be an option for you.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.